|
Mutations in epigenetic regulators in myelodysplastic syndromes
|
Jan 2012
|
Int J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Eculizumab treatment of paroxysmal nocturnal hemoglobinuria presenting as moyamoya syndrome in a 9-year-old male.
|
Jan 2012
|
Pediatr Blood Cancer
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis
|
Jan 2012
|
Int J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Combination strategies in myelodysplastic syndromes.
|
Jan 2012
|
Int J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Treatment of acquired aplastic anemia in children
|
Jan 2012
|
Hematology
|
aplastic anemia
|
|
The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes
|
Jan 2012
|
PLoS One
|
myelodysplastic syndromes (MDS)
|
|
Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes.
|
Jan 2012
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia.
|
Jan 2012
|
Neoplasma
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes in children: where are we today?
|
Jan 2012
|
Ochsner J
|
myelodysplastic syndromes (MDS)
|
